Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lilly’s Retevmo receives FDA approval to treat solid tumours
Retevmo (selpercatinib, 40 mg & 80 mg capsules) are indicated for the treatment of locally advanced or metastatic solid tumours in adult patients. Credit: Steve Buissinne from Pixabay.
Retevmo (selpercatinib, 40 mg & 80 mg capsules) are indicated for the treatment of locally advanced or metastatic solid tumours in adult patients. Credit: Steve Buissinne from Pixabay.